Catalyst Wire Dossier Catalyst Wire Dossier

Patuzumab

Patuzumab
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Patuzumab, covering 2024-12-17 to 2024-12-17. Get the full timeline:

Most recent: Clinical Trial Update: Darsilide Combined With AI, Trastuzumab and Patuzumab in the Neoadjuvant Treatment of HR+/HER2+ Breast Cancer [Phase 2]

See pricing